NeuroImage: Clinical (Jan 2016)

Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study

  • Klaus Kopitzki,
  • Andreas Oldag,
  • Catherine M. Sweeney-Reed,
  • Judith Machts,
  • Maria Veit,
  • Jörn Kaufmann,
  • Hermann Hinrichs,
  • Hans-Jochen Heinze,
  • Katja Kollewe,
  • Susanne Petri,
  • Bahram Mohammadi,
  • Reinhard Dengler,
  • Andreas R. Kupsch,
  • Stefan Vielhaber

DOI
https://doi.org/10.1016/j.nicl.2016.09.020
Journal volume & issue
Vol. 12, no. C
pp. 666 – 672

Abstract

Read online

Purpose: Aim of the present study was to investigate potential impairment of non-motor areas in amyotrophic lateral sclerosis (ALS) using near-infrared spectroscopy (NIRS) and diffusion tensor imaging (DTI). In particular, we evaluated whether homotopic resting-state functional connectivity (rs-FC) of non-motor associated cortical areas correlates with clinical parameters and disease-specific degeneration of the corpus callosum (CC) in ALS. Material and methods: Interhemispheric homotopic rs-FC was assessed in 31 patients and 30 healthy controls (HCs) for 8 cortical sites, from prefrontal to occipital cortex, using NIRS. DTI was performed in a subgroup of 21 patients. All patients were evaluated for cognitive dysfunction in the executive, memory, and visuospatial domains. Results: ALS patients displayed an altered spatial pattern of correlation between homotopic rs-FC values when compared to HCs (p = 0.000013). In patients without executive dysfunction a strong correlation existed between the rate of motor decline and homotopic rs-FC of the anterior temporal lobes (ATLs) (ρ = −0.85, p = 0.0004). Furthermore, antero-temporal homotopic rs-FC correlated with fractional anisotropy in the central corpus callosum (CC), corticospinal tracts (CSTs), and forceps minor as determined by DTI (p < 0.05). Conclusions: The present study further supports involvement of non-motor areas in ALS. Our results render homotopic rs-FC as assessed by NIRS a potential clinical marker for disease progression rate in ALS patients without executive dysfunction and a potential anatomical marker for ALS-specific degeneration of the CC and CSTs.

Keywords